Explore Business Standard
Coronavirus LIVE updates: Kerala recorded 12,297 cases, Maharashtra 2,692, Delhi 34, Karnataka 397, Tamil Nadu 1,531 cases in the last 24 hours. Stay tuned for corona updates
)
12:48 AM
11:56 PM
11:15 PM
10:07 PM
9:47 PM
9:11 PM
8:54 PM
Mumbai logged 433 new coronavirus cases and two fresh deaths on Tuesday, taking the infection tally to 7,45,163 and the toll to 16,129, a civic official said.
The city witnessed a rise in cases, but daily fatalities remained unchanged as compared to Monday, when it reported 341 infections cases and two deaths. According to the BMC official, with 31,969 COVID-19 tests conducted in the last 24 hours, their cumulative number climbed to 1,05,34,673.
8:38 PM
8:29 PM
8:04 PM
7:50 PM
Ladakh on Tuesday reported three fresh COVID-19 cases, taking the tally to 20,825 while the active cases in the Union Territory came down to 50, officials said.
Ladakh has registered 207 Covid-related deaths -- 149 in Leh and 58 in Kargil -- since the outbreak of the pandemic last year.
Five patients of coronavirus infection were cured and discharged from hospitals, taking the tally of cured patients to 20,658, they said.
7:40 PM
With the addition of 63 fresh cases of Covid-19, the tally of infections in Maharashtra's Nashik district rose to 4,08,856 on Tuesday, an official said.
Apart from this, 71 patients were discharged from hospitals, while two died of the infection during the day, taking the toll to 8,641 and the count of recoveries to 3,99,314, the official said.
According to the district authorities, 357 casualties have been reported from Malegaon, 3,986 from Nashik city and 4,172 in other parts of the district so far.
7:14 PM
6:28 PM
6:05 PM
AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease.
The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The treatment may help protect people whose immune systems don't respond adequately to vaccination, AstraZeneca said.
5:45 PM
Twenty-nine of Odisha's 30 districts have been declared Green Zones', as active COVID-19 cases came down across the state, a health department official said.
Khurda was the only district identified as Yellow Zone' for reporting over 2,000 active cases, while the figure in all other districts stands at below 1,000, he said.
Meanwhile, the state registered 453 fresh COVID-19 cases on Tuesday, including 53 children under 18 years of age, raising the tally to 10,28,819.
5:01 PM
Andhra Pradesh logged 671 new COVID-19 infections, taking the tally to over 20.53 lakh, while the toll went up to 14,219 with 11 casualties.
West Godavari district accounted for the highest number of cases with 109 followed by Chittoor (102), a state government bulletin said on Tuesday, giving figures of the last 24 hours ending at 9 AM.
The active cases stood at 9,141. The total number of cases in the state stood at 20,53,863, while with 1,272 people being cured, the total recoveries are at 20,30,503.
4:51 PM
Convalescent plasma therapy is "futile" as a treatment for most critically ill COVID-19 patients, according to a study published on Tuesday.
The findings, published in the journal JAMA, are the latest from REMAP-CAP trial, which has enrolled thousands of patients in hundreds of hospitals globally to quickly determine what COVID-19 treatments work best in which patients.
"There were biologically plausible reasons to turn to convalescent plasma early in the pandemic when hundreds of thousands of people were getting sick and treatments had yet to be discovered," said study co-lead author Bryan McVerry, an associate professor at the University of Pittsburgh School of Medicine (UPMC) in the US.
4:31 PM
Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
J&J said it filed a request with the FDA to authorise boosters for people who previously received the company's one-shot vaccine. While company said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators.
Last month, the FDA authorised booster shots of Pfizer's vaccine for older Americans and other groups with heightened vulnerability to COVID-19. It's part of a sweeping effort by the Biden administration to shore up protection amid the delta variant and potential waning vaccine immunity.
3:45 PM
With the gradual easing of restrictions on movement and the national vaccination drive in full swing across the country, the Uttarakhand government expects tourist footfalls to gather momentum and reach the pre-COVID-19 levels 2022 onwards.
"Even with the restrictions on the number of visitors in certain destinations due to the pandemic, we are witnessing full bookings.
"Therefore, looking at the current demand we are expecting the tourist footfalls to gather momentum after the vaccination drive and the sector is likely to reach pre-Covid levels 2022 onwards," Uttarakhand Tourism secretary and Uttarakhand Tourism and Development Board (UTDB) CEO Dilip Jawalkar told PTI.
However, the state is taking precautionary measures and seeing the further possibility of a third wave this year, he noted.
3:40 PM
Jammu and Kashmir's Ramban district has vaccinated all eligible beneficiaries with at least one dose of COVID-19 vaccine, and nearly 45 per cent of them have taken their second dose, officials said on Tuesday.
On September 15, Samba had become the first district in the union territory to vaccinate all people in the 18-44 age group with at least one dose of COVID-19 vaccine.
Amid apprehensions of a third wave of the pandemic, good news is coming from Ramban, where 100 per cent coverage of first Covid vaccine dose has been achieved, even as 45 per cent of beneficiaries have taken both doses, Chief Medical Officer, Ramban, Dr Mohammad Freed Bhat said.
3:08 PM
Russia recorded 25,110 new Covid-19 cases in the last 24 hours, down from 25,781 the day before, bringing the cumulative total to 7,637,427, the federal response center said on Tuesday.
"Over the past day, 25,110 Covid-19 cases were confirmed across 85 Russian regions, including 2,110 cases (8.4%) without clinical symptoms," the center said, adding that the rate of increase fell to 0.33%.
Moscow has the highest number of new cases with 3,827 daily infections, down from 4,410 the day before. The Russian capital is followed by St. Petersburg with 1,894 cases, down from 2,198, and the Moscow region with 1,788 cases, up from 1,733.
2:42 PM
Pakistan on Monday confirmed 1,308 new COVID-19 cases and 54 more deaths, the National Command and Operation Center (NCOC) said on Tuesday.
The NCOC, a department leading campaign against the pandemic, said that the country's number of overall confirmed cases had risen to 1,252,656, including 1,178,883 recoveries.
The number of active cases has dropped to 45,826 who are under treatment across the country, while 3,110 are in critical condition.
2:38 PM
Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.
The researchers found that over the study period, effectiveness of the vaccine against all SARS-COV-2 infections declined, falling from 88 per cent within one month after receiving two vaccine doses to 47 per cent after six months.
2:04 PM
1:50 PM
1:20 PM
1:02 PM
12:12 PM
11:12 AM
Topics :CoronavirusDelta variant of coronavirusWorld Health OrganizationCoronavirus VaccineHealth Ministry
First Published: Oct 05 2021 | 7:56 AM IST